Jonathan Poole
2017 - Genocea Biosciences
In 2017, Jonathan Poole earned a total compensation of $1.2M as Former Chief Financial Officer at Genocea Biosciences, a 63% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $95,288 |
---|---|
Option Awards | $417,542 |
Salary | $390,625 |
Stock Awards | $300,006 |
Other | $6,295 |
Total | $1,209,756 |
Poole received $417.5K in option awards, accounting for 35% of the total pay in 2017.
Poole also received $95.3K in non-equity incentive plan, $390.6K in salary, $300K in stock awards and $6.3K in other compensation.
Rankings
In 2017, Jonathan Poole's compensation ranked 8,066th out of 14,666 executives tracked by ExecPay. In other words, Poole earned more than 45.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,066 | 45th |
Manufacturing | 3,038 | 47th |
Chemicals And Allied Products | 1,000 | 52nd |
Drugs | 783 | 55th |
Biological Products, Except Diagnostic Substances | 142 | 55th |
Poole's colleagues
We found five more compensation records of executives who worked with Jonathan Poole at Genocea Biosciences in 2017.
2017
William Clark
Genocea Biosciences
Chief Executive Officer
2017
Seth Hetherington
Genocea Biosciences
Chief Medical Officer
2017
Jessica Fletchner
Genocea Biosciences
Chief Scientific Officer
2017
Eric Hoffman
Genocea Biosciences
Former Chief Business Officer
2017
Pamela Carroll
Genocea Biosciences